Genetic-related and carbohydrate-related factors affecting liver fat accumulation

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 15, Issue 4, 2012, Pages 392-396

  Goran, Michael I ^a   Walker, Ryan ^a   Allayee, Hooman ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

fatty liver; genetic; obesity; sugar

Indexed keywords

BIOLOGICAL MARKER; CARBOHYDRATE; FRUCTOSE; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING PROTEIN 3; SUGAR; UNCLASSIFIED DRUG;

CARBOHYDRATE DIET; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GROWTH, DEVELOPMENT AND AGING; HISPANIC; HUMAN; LIPID STORAGE; LIPOGENESIS; LIVER METABOLISM; NONALCOHOLIC FATTY LIVER; NONHUMAN; REVIEW; SUGAR INTAKE;

ANIMALS; APOLIPOPROTEIN C-III; CARRIER PROTEINS; DIET; DIETARY CARBOHYDRATES; ENERGY INTAKE; FATTY LIVER; FRUCTOSE; HISPANIC AMERICANS; HUMANS; LIPASE; LIPOGENESIS; LIVER; MEMBRANE PROTEINS; POLYMORPHISM, GENETIC;

EID: 84862154709     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3283544477     Document Type: Review

References (31)

1. Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 2010; 51:1820-1832
2. Preiss D, Sattar N. Nonalcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond) 2008; 115:141-150
3. Maersk M, Belza A, Stodkilde-Jorgensen H, et al. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr 2012; 95:283-289
4. Le KA, Ith M, Kreis R, et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr 2009; 89:1760-1765
5. Stanhope KL, Schwarz JM, Keim NL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009; 119:1322-1334
6. Abdelmalek MF, Suzuki A, Guy C, et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 2010; 51:1961-1971
7. Silbernagel G, Machann J, Unmuth S, et al. Effects of 4-week very-highfructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial. Br J Nutr 2011; 106:79-86
8. Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40:1461-1465
9. Chalasani N, Guo X, Loomba R, et al. Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease. Gastroenterology 2010; 139:1567-1576
10. Speliotes EK, Yerges-Armstrong LM, Wu J, et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 2011; 7:e1001324
11. Victor RG, Haley RW, Willett DL, et al. The Dallas Heart Study: a populationbased probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol 2004; 93:1473-1480
12. Goran MI, Walker R, Le K-A, et al. Effects of PNPLA3 on liver fat and metabolic profile in Hispanic children and adolescents. Diabetes 2010; 59:3127-3130
13. Romeo S, Sentinelli F, Cambuli VM, et al. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. J Hepatol 2010; 53:335-338
14. Valenti L, Alisi A, Galmozzi E, et al. I148M patatin-like phospholipase domaincontaining 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology 2010; 52:1274-1280
15. Yang Z, Wen J, Tao X, et al. Genetic variation in the GCKR gene is associated with nonalcoholic fatty liver disease in Chinese people. Mol Biol Rep 2011; 38:1145-1150
16. Santoro N, Zhang CK, Zhao H, et al. Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents. Hepatology 2012; 55:781-789
17. Petersen KF, Dufour S, Hariri A, et al. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med 2010; 362:1082-1089
18. Kozlitina J, Boerwinkle E, Cohen JC, Hobbs HH. Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance. Hepatology 2011; 53:467-474
19. Sentinelli F, Romeo S, Maglio C, et al. Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans. Lipids Health Dis 2011; 10:93
20. Valenti L, Nobili V, Al-Serri A, et al. The APOC3 T-455Cand C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver. J Hepatol 2011; 55:1409-1414
21. Hyysalo J, Stojkovic I, Kotronen A, et al. Genetic variation in PNPLA3 but not APOC3 influences liver fat in NAFLD. J Gastroenterol Hepatol 2011. [Epub ahead of print]. doi: 10.1111/j.1440-1746.2011.07046.x
22. Romero-Gómez M. APOC3 polymorphisms and nonalcoholic fatty liver disease: resolving some doubts and raising others. J Hepatol 2011; 55:1184-1186
23. Davis JN, Le KA, Walker RW, et al. Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption. Am J Clin Nutr 2010; 92:1522-1527
24. Sevastianova K, Kotronen A, Gastaldelli A, et al. Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans. Am J Clin Nutr 2011; 94:104-111
25. Beer NL, Tribble ND, McCulloch LJ, et al. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum Mol Genet 2009; 18:4081-4088
26. He S, McPhaul C, Li JZ, et al. A sequence variation (I148 M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 2010; 285:6706-6715
27. Huang Y, Cohen JC, Hobbs HH. Expression and characterization of a PNPLA3 protein isoform (I148 M) associated with nonalcoholic fatty liver disease. J Biol Chem 2011; 286:37085-37093
28. Huang Y, He S, Li JZ, et al. A feed-forward loop amplifies nutritional regulation of PNPLA3. Proc Natl Acad Sci USA 2010; 107:7892-7897
29. Chen W, Chang B, Li L, Chan L. Patatin-like phospholipase domaincontaining 3/adiponutrin deficiency in mice is not associated with fatty liver disease. Hepatology 2010; 52:1134-1142
30. Basantani MK, Sitnick MT, Cai L, et al. Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome. J Lipid Res 2011; 52:318-329
31. Qiao A, Liang J, Ke Y, et al. Mouse patatin-like phospholipase domaincontaining 3 influences systemic lipid and glucose homeostasis. Hepatology 2011; 54:509-521